ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 748,13
1,37%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Agile Therapeutics Inc (AGRX)

  7. Agile Therapeutics Inc (AGRX) Actualités

AGRX

Agile Therapeutics (AGRX)

Agile Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:AGRX
DateHeureSourceTitreSymboleSociété
28/03/202413h05GlobeNewswire Inc.Agile Therapeutics Reports Fourth Quarter & Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
25/03/202421h30GlobeNewswire Inc.Agile Therapeutics Announces Delisting from NasdaqNASDAQ:AGRXAgile Therapeutics Inc
21/03/202411h35GlobeNewswire Inc.Correction - Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 28, 2024NASDAQ:AGRXAgile Therapeutics Inc
20/03/202413h15GlobeNewswire Inc.Agile Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Friday, March 22, 2024NASDAQ:AGRXAgile Therapeutics Inc
13/03/202412h31GlobeNewswire Inc.Agile Therapeutics Completes Pay-off of Debt and Remains Focused on Business Plan ExecutionNASDAQ:AGRXAgile Therapeutics Inc
23/02/202422h57Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AGRXAgile Therapeutics Inc
22/02/202415h01GlobeNewswire Inc.Agile Therapeutics Announces Exercise of Warrants for $4.8 Million Gross ProceedsNASDAQ:AGRXAgile Therapeutics Inc
15/02/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AGRXAgile Therapeutics Inc
15/02/202422h30GlobeNewswire Inc.Agile Therapeutics Announces Extension Granted by Nasdaq Hearings Panel to Regain Compliance with the Stockholders’ Equity Continued Listing Requirement & Provides Performance UpdateNASDAQ:AGRXAgile Therapeutics Inc
14/02/202402h02Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
07/02/202422h51Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
23/01/202415h29GlobeNewswire Inc.The Biden-Harris Administration Announces New Guidance to Enable Expanded Access to All FDA-Approved Contraceptives Without CostNASDAQ:AGRXAgile Therapeutics Inc
12/12/202314h01GlobeNewswire Inc.Agile Therapeutics Provides Update on Actions Being Taken to Strengthen the Affordable Care Act’s No-Cost Contraceptive Coverage RequirementNASDAQ:AGRXAgile Therapeutics Inc
11/12/202323h30Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:AGRXAgile Therapeutics Inc
09/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AGRXAgile Therapeutics Inc
09/11/202314h05GlobeNewswire Inc.Agile Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/10/202314h05GlobeNewswire Inc.Agile Therapeutics to Report Third Quarter 2023 Financial Results and Provide Business Update on Thursday, November 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
04/10/202322h45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
04/10/202322h30GlobeNewswire Inc.Agile Therapeutics Reports an Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:AGRXAgile Therapeutics Inc
05/09/202314h05GlobeNewswire Inc.Agile Therapeutics to Present at the H.C. Wainwright 25th Annual Global Investment ConferenceNASDAQ:AGRXAgile Therapeutics Inc
25/08/202322h02Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AGRXAgile Therapeutics Inc
22/08/202314h30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:AGRXAgile Therapeutics Inc
09/08/202314h05GlobeNewswire Inc.Agile Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate UpdateNASDAQ:AGRXAgile Therapeutics Inc
26/07/202314h30GlobeNewswire Inc.Agile Therapeutics to Report Second Quarter 2023 Financial Results and Provide Business Plan Updates on Wednesday, August 9, 2023NASDAQ:AGRXAgile Therapeutics Inc
27/06/202322h47Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AGRXAgile Therapeutics Inc
26/06/202314h01GlobeNewswire Inc.Agile Therapeutics Announces the Availability of Twirla® to MMCAP Infuse MembersNASDAQ:AGRXAgile Therapeutics Inc
23/06/202318h05GlobeNewswire Inc.Agile Therapeutics Commends the Biden Administration’s Commitment to Strengthening Access to Affordable, High-Quality Contraception and Family Planning ServicesNASDAQ:AGRXAgile Therapeutics Inc
15/06/202322h05GlobeNewswire Inc.Agile Therapeutics Announces the Availability of Twirla® through FPA Women’s HealthNASDAQ:AGRXAgile Therapeutics Inc
14/06/202322h36Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AGRXAgile Therapeutics Inc
13/06/202322h05GlobeNewswire Inc.Agile Therapeutics Announces New Agreement with vitaCare® Prescription Services to Improve Access to Twirla®NASDAQ:AGRXAgile Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:AGRX

Dernières Valeurs Consultées

EU
ACA
Credit Agricole
EU
MC
Lvmh Moet Hennessy Louis...
EU
VK
Vallourec
SPI
SP500
S&P 500
EU
ORA
Orange
EU
PX1
CAC 40
EU
AF
Air FranceKLM
EU
CS
Axa
EU
PX4
SBF 120
NYSE
JPM
JP Morgan Chase
NASDAQ
AMZN
Amazon.com
EU
EN
Bouygues
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés